Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Legislation limiting malpractice damages passes House

Noneconomic damages in certain medical malpractice lawsuits would be capped at $250,000 under a bill passed through the House with only Republican support on June 28.

Cleveland Clinic CEO: ‘Deep financial trouble’ for hospitals under Senate ACA repeal bill

Toby Cosgrove, MD, CEO of the Cleveland Clinic, said Senate Republicans’ Better Care Reconciliation Act would squeeze hospitals already operating on thin margins without addressing the “root cause” of rising healthcare costs.

Internists Make Recommendations at Meeting With HHS Secretary

The American College of Physicians (ACP) today told a meeting convened by Health and Human Services (HHS) Department Secretary Tom Price that it has long identified reducing excessive administrative tasks as an important objective. The purpose of the meeting was to evaluate the impact of government requirements on the clinician-patient relationship.  

Thumbnail

HFMA 2017: 2 out of 3 patients don’t pay their hospitals bills in full

68 percent of patients with hospital bills under $500 didn’t pay off the full balance by the end of 2016, according a TransUnion Health study released at the Healthcare Financial Management Association (HFMA) conference in Orlando.

Personalized technology brings stimulation to dementia patients

Patients with dementia living in long-term care facilities are often on their own when it comes to mental stimulation. Without much interaction, many patients develop behaviors such as hitting, screaming and wandering. A study, set to be presented at the 2017 International Symposium on Human Factors and Ergonomics in Health Care, explains how a new interactive tool is able to increase engagement and improve outcomes.

Thumbnail

Senate to delay ACA replacement vote until after July 4 recess

The Senate will not vote on the Republican plan to repeal and replace the Affordable Care Act before the July 4 recess. Majority Leader Mitch McConnell, R-Kentucky, informed his Republican colleagues at a June 27 lunch, according to multiple news outlets.

Seattle firm aims to develop self-driving hospital to go to patients

Artefact, a Seattle-based design firm, is bringing the hospital to patients with what it calls a hospital in a self-driving car. "Aim" aims to bring healthcare into the future with all the amenities of a hospital without the need to travel.

Thumbnail

HFMA 2017: LexisNexis’ Rick Ingraham on using social determinants for ‘proactive patient outreach’

Addressing social determinants of health has been labeled a priority by many studies and healthcare organizations, but that data can also be used by health plans to assess a member’s future risk.

Displaying 4489 - 4496 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup